BioCentury
ARTICLE | Company News

La Jolla Pharmaceutical, Solana Therapeutics deal

January 30, 2012 8:00 AM UTC

Solana reverse-merged with La Jolla. The new entity, which retains the name La Jolla, will focus on development of Solana's GCS-100, which it acquired along with related assets from Prospect Therapeu...